Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $18.61 Million |
|---|---|
| Enterprise Value | $-2,390,320.00 |
| Earnings per Share | $-0.04 |
| Beta | -0.22 |
| Outstanding Shares | 1,240,512,000 |
| P/E Ratio | -5.51 |
|---|---|
| PEG | 30.48 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 20.18 |
| Enterprise Value to EBIT | -5.28 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Acarix AB (publ) is a medical technology company that develops and introduces diagnostic solutions for cardiovascular conditions to markets including Germany, Sweden, the Middle East, Switzerland, Austria, and globally. Their key product...